AI assistant
Sending…
EQUIFAX INC — Director's Dealing 2022
Jan 4, 2022
30136_dirs_2022-01-04_3404d178-f402-40e8-958f-a33c0b328ae9.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: EQUIFAX INC (EFX)
CIK: 0000033185
Period of Report: 2021-12-31
Reporting Person: KELLEY JOHN J III (Chief Legal Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-12-31 | Common Stock | M | 2761.0000 | $191.4400 | Acquired | 9515.0000 | Direct |
| 2021-12-31 | Common Stock | M | 2188.0000 | $175.4800 | Acquired | 11703.0000 | Direct |
| 2021-12-31 | Common Stock | F | 3950.0000 | $291.5400 | Disposed | 7753.0000 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-12-31 | Stock Option/Right to Buy | $175.4800 | M | 2188.0000 | Disposed | 2026-02-21 | Common Stock (2188.0000) | Direct |
| 2021-12-31 | Stock Option/Right to Buy | $191.4400 | M | 2761.0000 | Disposed | 2026-02-21 | Common Stock (2761.0000) | Direct |
Footnotes
F1: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date.
F2: The option vests in three equal annual increments beginning 2/21/2021.
More from EQUIFAX INC
Regulatory Filings
2026
May 13
Major Shareholding Notification
2026
Apr 30
Regulatory Filings
2026
Apr 24
Interim / Quarterly Report
2026
Apr 21
Regulatory Filings
2026
Apr 21
Regulatory Filings
2026
Apr 21
Annual Report
2026
Mar 27
Regulatory Filings
2026
Mar 27
Proxy Solicitation & Information Statement
2026
Mar 27
Major Shareholding Notification
2026
Mar 26